SynthesisFrontiers in oncology2022

Pertuzumab combined with trastuzumab compared to trastuzumab in the treatment of HER2-positive breast cancer: A systematic review and meta-analysis of randomized controlled trials.

Xiaoyun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.